Stephen Glover

Stephen C.
Glover is the founder of ZyVersa Therapeutics Operating, Inc., founded in 2014, where the title held is Chairman & Chief Executive Officer.
Mr. Glover was the founder of Coherus Oncology, Inc., founded in 2010, where the title held was Chief Business Officer from 2010 to 2013.
Mr. Glover is the founder of ZyVersa Therapeutics, Inc., founded in 2014, where the title held is Chairman, President & Chief Executive Officer since 2022.
Current jobs include Chairman at PDS Biotechnology Corp.
since 2019; Director at Wallace H.
Coulter Foundation, Biogene Therapeutics, Inc., Asclepius Life Sciences Fund LP, Inflamacore LLC, and Two B Pharma; and Director at Oncolytics Biotech, Inc. starting in 2026.
Former jobs include Chairman at Ambrx Biopharma Cayman, Inc. from 2023 to 2024; Chairman at Ambrx, Inc.; Director at INCON Co., Ltd. and Auriga Laboratories, Inc.; Senior Vice President-Brand Operations at Andrx Corp.
from 2003 to 2006; President at Insmed Therapeutic Proteins from 2007 to 2009; Chief Business Officer & Executive Vice President at Insmed, Inc. from 2007 to 2010; Senior Vice President & General Manager at Andrx Laboratories, Inc.; and Senior Vice President & General Manager at Watson Therapeutics, Inc. Education includes undergraduate studies at Illinois State University.